Solvonis Therapeutics plc

Investor Webinar

An investor webinar presented by Anthony Tennyson, Chief Executive Officer, and Professor David Nutt, Chief Scientific Officer, of Solvonis Therapeutics plc (LSE: SVNS). The webinar will be chaired by experienced in-house analyst Barry Gibb.

The webinar will focus on Solvonis’ SVN-001 severe alcohol use disorder programme, its broader addiction and mental health pipeline, and the clinical and commercial milestones underpinning its ambition to become a leader in the sector.

Turner Pope Investments will host the webinar on Thursday, 15 October 2026.

Access our research notes: